Although p53 mutations are relatively scarce in AML, non-mutational p53 abnormalities (e.g., altered post-translational modifications, p53 expression level or subcellular localization) appear to be rather frequent in AML [69]. The gene discussed is TP53; the disease is acute myeloid leukemia.